Dr. Dinesh Guna




Dr. Dinesh MBBS (NUS) is a licensed general practitioner (GP) in Singapore with a passion for sustainable initiatives that improve the quality, affordability, and accessibility of healthcare. Dr. Dinesh has managed complex initiatives from health promotion/community-based screening programs in underprivileged populations, to multinational health technology research spanning across industries, by leading multidisciplinary teams to execute aligned objectives. His current scientific research interests include Ophthalmology, Infectious Disease, Public Health, and Medical Technology.

He is experienced in project management and multinational applied clinical research having served as Head (Health Informatics) of the Collaborative Ocular Tuberculosis Study (COTS) group (2011-2019). COTS is a cloud computing-enabled study involving over 30 hospitals from 10 countries to better understand ocular tuberculosis (TB), a prevalent infectious disease that disproportionately affects the poor, as an early opportunity to address TB infection using big data.


1. NUS Alumnus of the Year 2019 (Medicine)
2. Commonwealth Fellow (Innovation)
3. Best Poster Award (Health Education), 2018 Singhealth DUKE-NUS Scientific Congress

1. Gunasekeran DV. Technology and chronic disease management. Lancet Diabetes Endocrinol. 2018 Feb;6(2):91
2. Gunasekeran DV. Invited Commentary: Treating the Patient with Uveitis as an Individual – Not a Disease. JAMA Ophthalmol. 2019;137(2):206-207.
3. DS Ting, Gunasekeran DV, Wickham L, TY Wong. Next generation telemedicine platforms to screen and triage. Br J Ophthalmol. 2019. [Epub before print]
4. Gunasekeran DV, Liu Z, Tan WJ, Koh J, Cheong CP, Tan LH, Lau CS, Phuah GK, Manuel NDA, Chia CC, Seng GS, Tong N, Huin MH, Dulce SV, Yap S, Ponampalam K, Ying H, Ong MEH, Ponampalam R. Evaluating Safety and Efficacy of Follow-up for Patients With Abdominal Pain Using Video Consultation (SAVED Study): Randomized Controlled Trial. J Med Internet Res 2020;22(6):e17417.
5. Gunasekeran DV, Agrawal R, Testi I, Agarwal A, Mahajan S, Nguyen QD, Pavesio C, Gupta V; Collaborative Ocular Tuberculosis Study (COTS) Group. Lessons in Digital Epidemiology from COTS-1: Coordinating Multicentre Research across 10 Countries Using Operational and Technology Innovation to Overcome Funding Deficiencies. Ocul Immunol Inflamm. 2020 Apr 22:1-7
6. Z Liu, M Ng, DV Gunasekeran, H Li, K Ponampalam, R Ponampalam. Mobile technology: Usage and perspective of patients and caregivers presenting to a tertiary care emergency. World J Emerg Med. 2020;11(1):5-11.
7. Xie Y and Nguyen QD, Lim, G, Bellemo V, Gunasekeran DV, Yip MYT, Hamzah H, Hsu W, Lee ML, Tan CSH, Wong HT, Tan, Gavin SW, Lamoureux EL, Wong TY, Finkelstein EA, Ting DSW. Artificial Intelligence for Teleophthalmology-Based Diabetic Retinopathy Screening in a National Program: A Modelledn Economic Analysis Study. LANCET Digital Health. E-pub 2020.
8. Agrawal R and Gunasekeran DV*, Grant R, Agarwal A, Onn MK, Nguyen QD, Pavesio C, Gupta V, COTS-1 Study Group. Clinical features and outcomes of patients with TB uveitis treated with anti-tubercular therapy (ATT) in COTS-1. JAMA Ophthalmol. 2017 Dec;135(12):1318-1327.
9. Chia KJW, Gunasekeran DV, Laude A. The Impact of Switching Anti-Vascular Endothelial Growth Factor Therapy in the Management of Exudative Age-Related Macular Degeneration. Ophthalmic Surg Lasers Imaging Retina. 2017 Oct;48(10):859-869.
10. Bansal S, Gunasekeran DV, Ang B, Lee J, Khandelwal R, Sullivan P, Agrawal R. Controversies in Pathology and Management of Hyphema. Surv Ophthalmol. 2016 May-Jun;61(3):297-308. 


CHAS, Bupa, Aetna


Equity investment in Doctorbell (acquired 2018),  AskDr, Shyfts, and VISRE. Receipt of travel funding from the Commonwealth Fellowship award, Mobile Health Education grant, and the National Youth Fund award for clinical research training at Oxford University and Stanford University. 
This physician-mediated patient support community is for discussions relating to eye care.
Discussions relating to the Corona Virus Disease 2019. Help our community spread awareness, education and debunk fake news or misinformation about the 2019 Coronavirus outb...
Join our community in safely discussing general health concerns you have for yourself or for your loved ones. Our community is Doctor moderated.